Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1996
09/19/1996CA2215383A1 Human tumor necrosis factor receptor
09/19/1996CA2215382A1 Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women
09/19/1996CA2215373A1 Use of antiestrogens for male birth control
09/19/1996CA2215336A1 Methods for the treatment of thrombosis
09/19/1996CA2215307A1 Pharmaceutical compositions and kits for preventing erectile dysfunction
09/19/1996CA2215201A1 17-difluoromethylene-estratrienes
09/19/1996CA2215061A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2215046A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties
09/19/1996CA2215022A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2214993A1 Cephalomannine epoxide, its analogues and a method for preparing the same
09/19/1996CA2214850A1 Novel benzothiophene compounds and methods
09/19/1996CA2214831A1 The pharmacological use of certain cystine derivatives
09/19/1996CA2214823A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/19/1996CA2214799A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996CA2214779A1 Use of nitric oxide donor and/or substrate for inducing cervical dilation
09/19/1996CA2214490A1 Method for treatment of autoimmune diseases using interferon-tau
09/19/1996CA2214450A1 Novel benzofuran pharmaceutical compounds
09/19/1996CA2214416A1 Novel naphthyl pharmaceutical compounds
09/19/1996CA2214261A1 Novel benzothiophene pharmaceutical compounds
09/19/1996CA2213749A1 Adenosine as a positive inotrop in the compromised heart
09/19/1996CA2211729A1 6-aryl pyrazolo[3,4-d¦pyrimidin-4-ones and compositions and methods of use thereof
09/19/1996CA2211669A1 6-substituted pyrazolo [3,4-d¦ pyrimidin-4-ones and compositions and methods of use thereof
09/19/1996CA2211326A1 Substituted n-arylmethyl and heterocyclylmethyl-1h-pyrazolo[3,4-b¦quinolin-4-amines and compositions and methods of use thereof
09/19/1996CA2211317A1 Substituted n-cycloalkylmethyl-1h-pyrazolo[3,4-b¦quinolin-4 amines and compositions and methods of use thereof
09/19/1996CA2190187A1 Use of a 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole derivative for treating allergic conjunctivitis
09/18/1996EP0732334A1 Piperidine derivatives, process for their preparation and their therapeutic application
09/18/1996EP0732333A1 Indazolecarboxamides
09/18/1996EP0732332A1 Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
09/18/1996EP0732331A1 Novel benzothiophene compounds and methods for inhibiting lipoxygenase and leukotrienes
09/18/1996EP0732329A1 Chroman derivative
09/18/1996EP0732328A1 Aromatic heterocyclic compounds, pharmaceutical and cosmetic compositions containing them and their uses
09/18/1996EP0732102A2 Composite for the treatment of acute myocardial infarction containing hirudin and acetylsalicyclic acid
09/18/1996EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals
09/18/1996EP0732064A1 Bitterness-relieving agent
09/18/1996EP0731992A1 High-density interconnect technique
09/18/1996EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
09/18/1996EP0731835A1 Antisense oligonucleotides having tumorigenicity-inhibiting activity
09/18/1996EP0731812A1 POLY-beta-1-4-N-ACETYLGLUCOSAMINE
09/18/1996EP0731809A1 Chirally enriched synthetic phosphonate oligomers
09/18/1996EP0731808A1 Nucleosides and oligonucleotides containing boron clusters
09/18/1996EP0731807A1 N-2 substituted purines
09/18/1996EP0731803A1 Novel furanodiazepines
09/18/1996EP0731802A1 N-substituted azabicycloalkane derivatives as neuroleptika asf
09/18/1996EP0731801A1 Substituted aminoalkylaminopyridines
09/18/1996EP0731796A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
09/18/1996EP0731795A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
09/18/1996EP0731793A1 1,5-diphenyl pyrazole compounds for treatment of inflammation
09/18/1996EP0731792A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731791A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731790A1 Tachykinin antagonists
09/18/1996EP0731789A1 Dp-iv-serine protease inhibitors
09/18/1996EP0731788A1 Prolyl endopeptidase inhibitors
09/18/1996EP0731787A1 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
09/18/1996EP0731712A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
09/18/1996EP0731711A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
09/18/1996EP0731708A1 Extract from the leaves of ginkgo biloba
09/18/1996EP0731706A1 Use of dimeticone for treating aphthae and stomatitis
09/18/1996EP0731705A1 Use of dimeticone for treating constipation
09/18/1996EP0731704A1 Synthetic glycoamines that promote or inhibit cell adhesion
09/18/1996EP0731702A1 Use of theophylline for the manufacture of a medicament for the treatment of asthma
09/18/1996EP0731701A1 Tablet or capsule containing a stable type 1 ranitidine hydrochloride
09/18/1996EP0731700A1 Medicament for treating heart insufficiency
09/18/1996EP0731699A1 Method of reducing body fat in animals by the administration of conjugated linoleic acid
09/18/1996EP0731698A1 Modafinil having defined particle size
09/18/1996EP0731697A1 Ssi tyrphostins and pharmaceutical compositions
09/18/1996EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups
09/18/1996EP0731694A1 Opioid formulations for treating pain
09/18/1996EP0731688A1 Aerosol drug formulations for use with non-cfc propellants
09/18/1996EP0731686A1 Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances
09/18/1996EP0666855B1 4-quinolinyl derivatives with anti-helicobacter activity
09/18/1996EP0643780B1 Multiple solvent cleaning system
09/18/1996EP0626369B1 Benzenesulfonamide derivative
09/18/1996EP0624090B1 Reversal of multi-drug resistance by tetraarylethylenes
09/18/1996EP0588799B1 New sulphonamides, process for preparing the same and medicaments containing these compounds
09/18/1996EP0585314B1 Novel heterocyclic carboxylic acids
09/18/1996EP0565631B1 Anti-viral compounds
09/18/1996EP0560794B1 Substituted 1,3-oxathiolanes with antiviral properties
09/18/1996EP0553248B1 Novel 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents
09/18/1996EP0533896B1 Inhalant based on taurine
09/18/1996EP0531370B1 Inhibition of viral infection
09/18/1996EP0527941B1 Identification of novel drugs and reagents
09/18/1996EP0511991B1 Pharmaceutical formulation containing penciclovir
09/18/1996EP0429676B1 Drug for improving brain function
09/18/1996CN1131437A Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
09/18/1996CN1131424A Androstenone derivative
09/18/1996CN1131421A Novel substituted propane-2-ol derivatives
09/18/1996CN1131420A Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
09/18/1996CN1131416A Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
09/18/1996CN1131415A Triaryl-ethylene derivatives for use in therapy
09/18/1996CN1131414A Aminoindanes and related compounds useful as calcium-channel antagonists
09/18/1996CN1131393A Biochemically balanced peritoneal dialysis solutions
09/18/1996CN1131392A Nitric oxide donor composition and method for treatment of anal disorders
09/18/1996CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
09/18/1996CN1131390A Plaster containing (E)-2-(P-fluorophenethyl)-3-fluoroallylamine for treatment of alzheimer's disease
09/18/1996CN1131389A Use of oligosaccharides for prevention and treatment of tissue ageing
09/18/1996CN1131158A Steroids with 17-spiromethylene lactone or lactol group
09/18/1996CN1131155A New tricyclic oxime ethers, processes for their preparation and pharmaceutical compositions containing them
09/18/1996CN1131154A 8-oxy-5,8-dihydro-6H-dibenzo|a,g¨quinolizine-13-propionic acid derivant, its preparation method and medicinal use thereof
09/18/1996CN1131153A 1-oxy-2-(phenylsulfonamido-) amyl piperidine derivant, its preparation method and medicinal use thereof
09/18/1996CN1131150A 3-phenyl isoquinolin-1(2H)-one derivant, its preparation method and medicinal use thereof
1 ... 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 6889 6890 6891 6892 6893 6894 6895 6896 6897 6898 6899 ... 7860